A network medicine framework for multi-modal data integration in therapeutic target discovery
Baltusyte, G.; Toleman, I.; Jones, J.; Saeb-Parsy, K.; Han, N.
Show abstract
The high cost and attrition rate of drug development underscore the need for more effective strategies for therapeutic target discovery. Here, we present a network medicine-based machine learning framework that integrates single-cell transcriptomics, bulk multi-omic profiles, genome-wide CRISPR perturbation screens, and protein-protein interaction networks to systematically prioritise disease-specific targets. Applied to clear cell renal cell carcinoma, the framework successfully recovered established targets and predicted five therapeutic candidates, with subsequent in vitro validation demonstrating that among these, ENO2 inhibition had the strongest anti-tumour effect, followed by LRRK2, a repurposing candidate with phase III Parkinsons disease inhibitors. The proposed approach advances target discovery by moving beyond single-feature, single-modality heuristics to a scalable, machine learning-driven strategy that is generalisable across diseases.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Personalized Cancer Therapy Prioritization Based on Driver Alteration Co-occurrence Patterns 96%
- Spatial transcriptomic analysis of Sonic Hedgehog Medulloblastoma identifies that the loss of heterogeneity and promotion of differentiation underlies the response to CDK4/6 inhibition 95%
- Retroelement co-option disrupts the cancer transcriptional programme 94%
Similar papers in this journal
- Angiogenic and Immune Predictors of Neoadjuvant Axitinib Response in Renal Cell Carcinoma with Venous Tumour Thrombus 95%
- Machine learning-based tissue of origin classification for cancer of unknown primary diagnostics using genome-wide mutation features 95%
- Projecting genetic associations through gene expression patterns highlights disease etiology and drug mechanisms 95%
Similar papers in this journal
- Impact of between-tissue differences on pan-cancer predictions of drug sensitivity 95%
- Network models of protein phosphorylation, acetylation, and ubiquitination connect metabolic and cell signaling pathways in lung cancer 95%
- Machine learning-based investigation of the cancer protein secretory pathway 94%
Similar papers in this journal
- Transcriptomic analyses of MYCN-regulated genes in anaplastic Wilms' tumour cell lines reveals oncogenic pathways and potential therapeutic vulnerabilities 93%
- Propagated circulating tumor cells uncovers the rople of NFκB and COP1 in metastasis 93%
- KLF4 induces Mesenchymal-Epithelial Transition (MET) by suppressing multiple EMT-inducing transcription factors 92%
Similar papers in this journal
- SHEST: Single-cell-level artificial intelligence from haematoxylin and eosin morphology for cell type prediction and spatial transcriptomics reconstruction 94%
- PheCode-guided multi-modal topic modeling of electronic health records improves disease incidence prediction and GWAS discovery from UK Biobank 93%
- StereoMM: A Graph Fusion Model for Integrating Spatial Transcriptomic Data and Pathological Images 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.